Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population

Maria Isabel Mendonça, Eva Henriques, Sofia Borges, Ana Célia Sousa, Andreia Pereira, Marina Santos, Margarida Temtem, Sónia Freitas, Joel Monteiro, João Adriano Sousa, Ricardo Rodrigues, Graça Guerra, Roberto Palma Dos Reis

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


The inclusion of a genetic risk score (GRS) can modify the risk prediction of coronary artery disease (CAD), providing an advantage over the use of traditional models. The predictive value of the genetic information on the recurrence of major adverse cardiovascular events (MACE) remains controversial. A total of 33 genetic variants previously associated with CAD were genotyped in 1587 CAD patients from the GENEMACOR study. Of these, 18 variants presented an hazard ratio >1, so they were selected to construct a weighted GRS (wGRS). MACE discrimination and reclassification were evaluated by C-Statistic, Net Reclassification Index and Integrated Discrimination Improvement methodologies. After the addition of wGRS to traditional predictors, the C-index increased from 0.566 to 0.572 (p=0.0003). Subsequently, adding wGRS to traditional plus clinical risk factors, this model slightly improved from 0.620 to 0.622 but with statistical significance (p=0.004). NRI showed that 17.9% of the cohort was better reclassified when the primary model was associated with wGRS. The Kaplan-Meier estimator showed that, at 15-year follow-up, the group with a higher number of risk alleles had a significantly higher MACE occurrence (p=0.011). In CAD patients, wGRS improved MACE risk prediction, discrimination and reclassification over the conventional factors, providing better cost-effective therapeutic strategies.

Original languageEnglish
Article numbere20200448
Pages (from-to)e20200448
JournalGenetics and Molecular Biology
Issue number2
Publication statusPublished - 2021


Dive into the research topics of 'Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population'. Together they form a unique fingerprint.

Cite this